Il6 and Acute Pressor Response to Psychological Stress

Il6 和对心理压力的急性升压反应

基本信息

  • 批准号:
    7433775
  • 负责人:
  • 金额:
    $ 25.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

We have new data showing marked tachycardic and hypertensive responses in male mice switched to cages previously occupied by a different male mouse. The pressor, but not the heart rate or activity, effect of this stress is blunted significantly in interleukin-6 (IL-6) knockout mice. We also have new evidence that shows considerable acute and chronic interaction with the sympathetic and renin-angiotensin systems. This project will test the hypothesis that interleukin-6 (IL-6) plays a major role in sympathetic- and angiotensin II-mediated hypertensive responses to psychosocial stress. The Specific Aims are: 1) to test the hypothesis that IL-6 contributes significantly to the acute pressor response to psychological stress. We will use acute cage-switch stress testing in mice to determine whether a) IL-6 knockout (KO) mice have a blunted increase in blood pressure compared to wild-type (WT) mice; b) TNF-a knockout mice have an attenuated pressor response to cage switch, similar to IL-6 knockout; c) restoring IL-6 in KO mice will restore a normal pressor response to psychological stress; d) the pressor response in WT mice injected with IL-6 antibody will mimic the response in IL-6 KO mice. 2) to determine the role of IL-6 in mediating the bi-directional blood pressure interactions between acute psychosocial stress and chronic hypertension. These experiments will determine whether: a) cage-switch stress causes IL-6-dependent hypertension after the initial pressor response has subsided; b) Angll hypertension increases the dependence of psychosocial stress-induced pressor responses on IL-6; c) repeated cage-switch stress testing causes a greater increase in MAP over time in WT versus KO mice. 3) to test the hypothesis that the sympathetic nervous system initiates IL-6-dependent blood pressure increases during acute stress, directly and through stimulation of the renin-angiotensin system. We will study the blood pressure increase during acute cage-switch stress testing and test the hypotheses that: a) a-/b-adrenergic receptor blockade will block the pressor response more in WT than in IL-6 KO mice; b) Angll receptor blockade will block the pressor response more in WT compared to IL-6 KO mice; c) the effect of adrenergic blockade will be blunted in mice with the Angll system clamped at normal.
我们有新的数据显示,雄性小鼠在转换到先前由不同雄性小鼠占据的笼子中时出现了明显的心动过速和高血压反应。在白细胞介素-6(IL-6)基因敲除小鼠中,这种应激的升压效应显著减弱,但心率或活动没有减弱。我们也有新的证据表明,相当大的急性和慢性相互作用与交感神经和肾素血管紧张素系统。本项目将检验白细胞介素-6(IL-6)在交感神经和血管紧张素II介导的高血压对心理社会应激的反应中起主要作用的假设。具体目标是: 1)以验证IL-6在心理应激的急性升压反应中有重要作用的假设。我们将在小鼠中使用急性笼子转换压力测试来确定是否 a)与野生型(WT)小鼠相比,IL-6敲除(KO)小鼠具有钝性的血压增加; B)TNF-α敲除小鼠对笼子转换具有减弱的升压反应,类似于IL-6敲除; c)在KO小鼠中恢复IL-6将恢复对心理应激的正常升压反应; d)注射IL-6抗体的WT小鼠中的升压反应将模拟IL-6 KO小鼠中的反应。 2)确定IL-6在介导急性心理社会应激和慢性高血压之间的双向血压相互作用中的作用。这些实验将确定: a)初始加压反应消退后,转换笼应激导致IL-6依赖性高血压; B)AngII高血压增加了心理社会应激诱导的升压反应对IL-6的依赖性; c)在WT与KO小鼠中,重复的换笼应激测试导致MAP随时间的更大增加。 3)为了检验交感神经系统在急性应激期间直接和通过刺激肾素-血管紧张素系统启动IL-6依赖性血压升高的假设。我们将研究急性换笼应激试验期间的血压升高,并检验以下假设: a)a-/b-肾上腺素能受体阻断剂将在WT中比在IL-6 KO小鼠中更多地阻断升压反应; B)与IL-6 KO小鼠相比,AngII受体阻断将在WT中更多地阻断升压反应; c)肾上腺素能阻断的作用在AngII系统正常夹紧的小鼠中将减弱。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael W. Brands其他文献

Michael W. Brands的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael W. Brands', 18)}}的其他基金

Pathophysiology of insulin-regulated renal blood flow and sodium excretion
胰岛素调节肾血流量和钠排泄的病理生理学
  • 批准号:
    10440320
  • 财政年份:
    2020
  • 资助金额:
    $ 25.76万
  • 项目类别:
Pathophysiology of insulin-regulated renal blood flow and sodium excretion
胰岛素调节肾血流量和钠排泄的病理生理学
  • 批准号:
    10206134
  • 财政年份:
    2020
  • 资助金额:
    $ 25.76万
  • 项目类别:
Animals and Instrumentation Core
动物和仪器核心
  • 批准号:
    10094226
  • 财政年份:
    2017
  • 资助金额:
    $ 25.76万
  • 项目类别:
Damage-Associated Molecular Patterns in Hypertension
高血压损伤相关的分子模式
  • 批准号:
    10094220
  • 财政年份:
    2017
  • 资助金额:
    $ 25.76万
  • 项目类别:
Peach State Bridges to the Doctorate
桃州通往博士学位的桥梁
  • 批准号:
    9750021
  • 财政年份:
    2015
  • 资助金额:
    $ 25.76万
  • 项目类别:
Peach State Bridges to the Doctorate
桃州通往博士学位的桥梁
  • 批准号:
    8934722
  • 财政年份:
    2015
  • 资助金额:
    $ 25.76万
  • 项目类别:
Core--Animal
核心--动物
  • 批准号:
    7433780
  • 财政年份:
    2007
  • 资助金额:
    $ 25.76万
  • 项目类别:
Core B- Animal Core
核心B-动物核心
  • 批准号:
    7228248
  • 财政年份:
    2006
  • 资助金额:
    $ 25.76万
  • 项目类别:
Il6 and Acute Pressor Response to Psychological Stress
Il6 和对心理压力的急性升压反应
  • 批准号:
    7228243
  • 财政年份:
    2006
  • 资助金额:
    $ 25.76万
  • 项目类别:
Core B- Animal Core
核心B-动物核心
  • 批准号:
    7063187
  • 财政年份:
    2005
  • 资助金额:
    $ 25.76万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 25.76万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 25.76万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 25.76万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 25.76万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 25.76万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 25.76万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 25.76万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 25.76万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 25.76万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 25.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了